Genor Biopharma Holdings Limited (HK:6998) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Genor Biopharma Holdings Limited has announced a delay in dispatching its circular related to a major proposed merger and other corporate changes. The extension, granted to finalize necessary details and reviews, pushes the deadline to February 28, 2025. Investors are advised to remain cautious as the merger’s completion depends on several regulatory approvals.
For further insights into HK:6998 stock, check out TipRanks’ Stock Analysis page.